Literature DB >> 28667553

Properties and Immune Function of Cardiac Fibroblasts.

Milena B Furtado1,2, Muneer Hasham3.   

Abstract

This chapter will discuss the role of cardiac fibroblasts as a target of various immunological inputs as well as an immunomodulatory hub of the heart through interaction with immune cell types and chemokine or cytokine signaling. While the purpose of this chapter is to explore the immunomodulatory properties of cardiac fibroblasts, it is important to note that cardiac fibroblasts are not a homogeneous cell type, but have a unique embryological origin and molecular identity. Specific properties of cardiac fibroblasts may influence the way they interact with the heart microenvironment to promote healthy homeostatic function or respond to pathological insults. Therefore, we will briefly discuss these aspects of cardiac fibroblast biology and then focus on their immunomodulatory role in the heart.

Keywords:  Cardiovascular disease; Fibroblast; Heart; Immune response; Immunomodulator; Injury; Myofibroblast

Mesh:

Substances:

Year:  2017        PMID: 28667553     DOI: 10.1007/978-3-319-57613-8_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis.

Authors:  Jinhua Zhang; Yuxian Chen; Tufeng Chen; Bin Miao; Zuofu Tang; Xiao Hu; You Luo; Tong Zheng; Ning Na
Journal:  Clin Transl Med       Date:  2021-03

2.  miRNAs generated from Meg3-Mirg locus are downregulated during aging.

Authors:  Ana-Mihaela Lupan; Evelyn-Gabriela Rusu; Mihai Bogdan Preda; Catalina Iolanda Marinescu; Cristina Ivan; Alexandrina Burlacu
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682

3.  Cell Phenotype Transitions in Cardiovascular Calcification.

Authors:  Luis Hortells; Swastika Sur; Cynthia St Hilaire
Journal:  Front Cardiovasc Med       Date:  2018-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.